Logo image of SGHC

SUPER GROUP SGHC LTD (SGHC) Stock Fundamental Analysis

NYSE:SGHC - New York Stock Exchange, Inc. - GG00BMG42V42 - Common Stock - Currency: USD

8.28  -0.07 (-0.84%)

Fundamental Rating

5

Overall SGHC gets a fundamental rating of 5 out of 10. We evaluated SGHC against 135 industry peers in the Hotels, Restaurants & Leisure industry. SGHC has an excellent financial health rating, but there are some minor concerns on its profitability. SGHC has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

SGHC had positive earnings in the past year.
SGHC had a positive operating cash flow in the past year.
In multiple years SGHC reported negative net income over the last 5 years.
SGHC had a positive operating cash flow in each of the past 5 years.
SGHC Yearly Net Income VS EBIT VS OCF VS FCFSGHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 50M -50M 100M 150M 200M

1.2 Ratios

With a Return On Assets value of -1.10%, SGHC is not doing good in the industry: 68.70% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -2.02%, SGHC is in line with its industry, outperforming 48.85% of the companies in the same industry.
SGHC has a Return On Invested Capital of 10.40%. This is in the better half of the industry: SGHC outperforms 72.52% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SGHC is significantly above the industry average of 10.79%.
The 3 year average ROIC (17.17%) for SGHC is well above the current ROIC(10.40%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.1%
ROE -2.02%
ROIC 10.4%
ROA(3y)15.84%
ROA(5y)13.87%
ROE(3y)26.29%
ROE(5y)N/A
ROIC(3y)17.17%
ROIC(5y)N/A
SGHC Yearly ROA, ROE, ROICSGHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 50 100 150 200

1.3 Margins

SGHC has a Operating Margin of 5.22%. This is in the lower half of the industry: SGHC underperforms 62.60% of its industry peers.
SGHC's Operating Margin has declined in the last couple of years.
SGHC does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 5.22%
PM (TTM) N/A
GM N/A
OM growth 3Y-27.69%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGHC Yearly Profit, Operating, Gross MarginsSGHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 5 -5 10 -10 15

More info and screens

7

2. Health

2.1 Basic Checks

SGHC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, SGHC has about the same amount of shares outstanding.
Compared to 1 year ago, SGHC has a worse debt to assets ratio.
SGHC Yearly Shares OutstandingSGHC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 100M 200M 300M 400M
SGHC Yearly Total Debt VS Total AssetsSGHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

SGHC has an Altman-Z score of 7.69. This indicates that SGHC is financially healthy and has little risk of bankruptcy at the moment.
SGHC's Altman-Z score of 7.69 is amongst the best of the industry. SGHC outperforms 92.37% of its industry peers.
SGHC has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.37, SGHC belongs to the top of the industry, outperforming 92.37% of the companies in the same industry.
A Debt/Equity ratio of 0.05 indicates that SGHC is not too dependend on debt financing.
The Debt to Equity ratio of SGHC (0.05) is better than 85.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.37
Altman-Z 7.69
ROIC/WACC1.08
WACC9.61%
SGHC Yearly LT Debt VS Equity VS FCFSGHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 1.26 indicates that SGHC should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.26, SGHC is doing good in the industry, outperforming 64.89% of the companies in the same industry.
SGHC has a Quick Ratio of 1.26. This is a normal value and indicates that SGHC is financially healthy and should not expect problems in meeting its short term obligations.
SGHC has a better Quick ratio (1.26) than 67.94% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26
SGHC Yearly Current Assets VS Current LiabilitesSGHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

5

3. Growth

3.1 Past

SGHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.97%.
The Revenue has grown by 11.14% in the past year. This is quite good.
SGHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.51% yearly.
EPS 1Y (TTM)-18.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)11.14%
Revenue growth 3Y16.51%
Revenue growth 5YN/A
Sales Q2Q%12.88%

3.2 Future

Based on estimates for the next years, SGHC will show a very strong growth in Earnings Per Share. The EPS will grow by 64.11% on average per year.
The Revenue is expected to grow by 11.65% on average over the next years. This is quite good.
EPS Next Y104%
EPS Next 2Y94.74%
EPS Next 3Y64.11%
EPS Next 5YN/A
Revenue Next Year19.45%
Revenue Next 2Y13.98%
Revenue Next 3Y11.65%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SGHC Yearly Revenue VS EstimatesSGHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
SGHC Yearly EPS VS EstimatesSGHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 0.1 0.2 0.3 0.4 0.5

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 43.58, the valuation of SGHC can be described as expensive.
SGHC's Price/Earnings ratio is in line with the industry average.
SGHC's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 30.42.
Based on the Price/Forward Earnings ratio of 16.10, the valuation of SGHC can be described as correct.
79.39% of the companies in the same industry are more expensive than SGHC, based on the Price/Forward Earnings ratio.
SGHC is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.75, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 43.58
Fwd PE 16.1
SGHC Price Earnings VS Forward Price EarningsSGHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SGHC indicates a slightly more expensive valuation: SGHC is more expensive than 72.52% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as SGHC.
Industry RankSector Rank
P/FCF 50.18
EV/EBITDA 24.17
SGHC Per share dataSGHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SGHC's earnings are expected to grow with 64.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.42
PEG (5Y)N/A
EPS Next 2Y94.74%
EPS Next 3Y64.11%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.82%, SGHC is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.08, SGHC pays a better dividend. On top of this SGHC pays more dividend than 93.89% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.30, SGHC pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.82%

5.2 History

SGHC does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
SGHC Yearly Dividends per shareSGHC Yearly Dividends per shareYearly Dividends per share 2024 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2Y94.74%
EPS Next 3Y64.11%
SGHC Yearly Income VS Free CF VS DividendSGHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

More info and screens

SUPER GROUP SGHC LTD

NYSE:SGHC (2/20/2025, 2:45:23 PM)

8.28

-0.07 (-0.84%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-06 2024-11-06/bmo
Earnings (Next)02-25 2025-02-25/amc
Inst Owners7.5%
Inst Owner Change24.33%
Ins Owners5.77%
Ins Owner ChangeN/A
Market Cap4.15B
Analysts84
Price Target9.69 (17.03%)
Short Float %1.27%
Short Ratio2.67
Dividend
Industry RankSector Rank
Dividend Yield 4.82%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)112.42%
Min EPS beat(2)-1.96%
Max EPS beat(2)226.8%
EPS beat(4)2
Avg EPS beat(4)94.06%
Min EPS beat(4)-100%
Max EPS beat(4)251.4%
EPS beat(8)3
Avg EPS beat(8)45.68%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)9.93%
Min Revenue beat(2)9.42%
Max Revenue beat(2)10.44%
Revenue beat(4)4
Avg Revenue beat(4)6.94%
Min Revenue beat(4)1.57%
Max Revenue beat(4)10.44%
Revenue beat(8)6
Avg Revenue beat(8)3.82%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)22.58%
PT rev (3m)78.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)36.84%
EPS NY rev (3m)23.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)4.48%
Revenue NY rev (3m)5.33%
Valuation
Industry RankSector Rank
PE 43.58
Fwd PE 16.1
P/S 2.77
P/FCF 50.18
P/OCF 29.95
P/B 7.65
P/tB 17.15
EV/EBITDA 24.17
EPS(TTM)0.19
EY2.29%
EPS(NY)0.51
Fwd EY6.21%
FCF(TTM)0.17
FCFY1.99%
OCF(TTM)0.28
OCFY3.34%
SpS2.99
BVpS1.08
TBVpS0.48
PEG (NY)0.42
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.1%
ROE -2.02%
ROCE 13.16%
ROIC 10.4%
ROICexc 18.07%
ROICexgc 149.85%
OM 5.22%
PM (TTM) N/A
GM N/A
FCFM 5.52%
ROA(3y)15.84%
ROA(5y)13.87%
ROE(3y)26.29%
ROE(5y)N/A
ROIC(3y)17.17%
ROIC(5y)N/A
ROICexc(3y)34.83%
ROICexc(5y)N/A
ROICexgc(3y)196.54%
ROICexgc(5y)N/A
ROCE(3y)21.74%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-27.69%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.37
Debt/EBITDA 0.15
Cap/Depr 65.16%
Cap/Sales 3.73%
Interest Coverage 40.67
Cash Conversion 84.51%
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z 7.69
F-Score4
WACC9.61%
ROIC/WACC1.08
Cap/Depr(3y)46.84%
Cap/Depr(5y)34.86%
Cap/Sales(3y)2.67%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y104%
EPS Next 2Y94.74%
EPS Next 3Y64.11%
EPS Next 5YN/A
Revenue 1Y (TTM)11.14%
Revenue growth 3Y16.51%
Revenue growth 5YN/A
Sales Q2Q%12.88%
Revenue Next Year19.45%
Revenue Next 2Y13.98%
Revenue Next 3Y11.65%
Revenue Next 5YN/A
EBIT growth 1Y-11.45%
EBIT growth 3Y-15.76%
EBIT growth 5YN/A
EBIT Next Year313.7%
EBIT Next 3Y76.45%
EBIT Next 5YN/A
FCF growth 1Y-43.03%
FCF growth 3Y-17.1%
FCF growth 5YN/A
OCF growth 1Y-20.35%
OCF growth 3Y-4.24%
OCF growth 5YN/A